AccessibilityHelpAbout Us
Elekta Ab (publ) logo

Elekta Ab (publ)(OTC) EKTAF

Market Cap$1.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-57%
5 Year-51%
1 Year+12%
1 Month-3%
$5.21
-5.78%
-0.32Today
Elekta Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 5.212026-09-08
Elekta Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.94%USD 5.482026-08-26
1 month-3.21%USD 5.382026-08-07
3 month-18.1%USD 6.362026-05-29
Year to date-11.51%USD 5.882025-12-30
1 year+11.96%USD 4.652025-08-29
3 year-12.91%USD 5.982023-09-07
5 year-50.53%USD 10.522021-09-07
Since inception-57.36%USD 12.212003-08-22

Elekta Ab (publ) Financials at a Glance

Market Cap

$1.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 16.55B

Net Income (TTM)

-SEK 357.33M

EPS (TTM)

-$0.11

P/E Ratio

-48.33

Dividend

$0.26

Beta (Volatility)

0.29 (Low)

Price

$5.21

Volume

613

Open

$5.21

Previous Close

$5.21

Daily Range

$5.21 - $5.21

52-Week Range

$4.48 - $6.83

Estimated Earnings Date

Nov 25, 2026

EKTAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elekta Ab (publ)

Elekta AB (publ) is a global medical technology enterprise specializing in advanced clinical tools for cancer and neurological treatment. The company offers a comprehensive range of products and services designed to enhance patient care and improve treatment outcomes.

Products and Services
  • Leading radiotherapy solutions, including Versa HD and Elekta Unity MR-Linac
  • Comprehensive treatment management systems like MOSAIQ Plaza and Elekta Axis Cloud
  • Innovative brachytherapy products, including Elekta Studio and Flexitron afterloader
Growth Outlook
  • Recent quarterly revenue of SEK 3.52 billion indicates strong demand for products
  • TTM gross profit margin of 38.6% reflects effective cost management
  • Continued investment in R&D, with SEK 456 million allocated in the latest quarter
Financial Highlights
  • Net income of SEK 263 million in the latest quarter shows recovery from previous losses
  • Operating income margin improved to 11% in Q1 2026
  • Dividend yield of 4.4% offers attractive returns for investors
Elekta AB has established itself as a leader in the medical technology sector, particularly in oncology and neurosurgery. The company's innovative products, such as the Elekta Unity MR-Linac and the Leksell Gamma Knife series, are at the forefront of cancer treatment technology. With a focus on enhancing patient outcomes, Elekta continues to invest significantly in research and development, ensuring a robust pipeline of future innovations. The recent financial performance indicates a positive trajectory, with a notable increase in revenue and net income. The improvement in operating income margin suggests effective management strategies are in place, contributing to the company's overall financial health. Furthermore, the attractive dividend yield may appeal to income-focused investors. Overall, Elekta AB presents a compelling opportunity for potential investors interested in the healthcare technology sector, particularly those looking for companies with a strong commitment to innovation and patient care.
AI Generated • Aug 29, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

4,102

CEO

Jakob Just-Bomholt

Website

www.elekta.com

Headquarters

Stockholm, SD 113 68, SE

EKTAF Financials

Key Financial Metrics (TTM)

Gross Margin

38.62%

Operating Margin

6.35%

Net Income Margin

-2.18%

Return on Equity

-4.66%

Return on Capital

3.00%

Return on Assets

-1.36%

Earnings Yield

-2.07%

Dividend Yield

4.91%

Payout Ratio

-2.55%

Stock Overview

Market Cap

$1.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

382.08M

Volume

613

Avg. Volume

285.984

Financials (TTM)

Gross Profit

SEK 6.39B

Operating Income

SEK 1.05B

EBITDA

SEK 1.28B

Operating Cash Flow

SEK 1.97B

Capital Expenditure

-SEK 95.76M

Free Cash Flow

SEK 1.87B

Cash & ST Invst.

SEK 2.30B

Total Debt

SEK 6.80B

Elekta Ab (publ) Performance Analysis

Elekta Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30SEK 1,614,476,247-1.2%
20242024-04-30SEK 1,702,409,8715.4%
20252025-04-30SEK 1,706,628,4650.2%
20262026-04-30SEK 1,780,004,6264.3%
Elekta Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-10-3111.6%
Q32026-01-313.8%
Q42026-04-3012.0%
Q12026-07-31-25.5%
Elekta Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30SEK 0.24-30.5%
20242024-04-30SEK 0.3235.7%
20252025-04-30SEK 0.06-81.6%
20262026-04-30SEK -0.14N/A
Elekta Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-10-31114.3%
Q32026-01-31-95.7%
Q42026-04-30-8864.5%
Q12026-07-31130.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

SEK 3.52B

-3.4%

Gross Profit

SEK 1.50B

+11.7%

Gross Margin

42.56%

N/A

Market Cap

$1.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$484.82K

N/A

Employees

4,102

N/A

Net Income

SEK 263.00M

+145.8%

EBITDA

SEK 520.02M

+2.2%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

SEK 2.30B

-16.8%

Total Debt

SEK 6.80B

-12.1%

Accounts Receivable

SEK 6.61B

-13.7%

Inventory

SEK 3.48B

+14.9%

Long Term Debt

SEK 4.11B

-38.1%

Short Term Debt

SEK 2.71B

+145.1%

Return on Assets

-1.36%

N/A

Return on Invested Capital

8.58%

N/A

Free Cash Flow

-SEK 23.91M

+93.4%

Operating Cash Flow

SEK 0.00

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RTEZRest Ez Inc.
$70.00+0.00%
GENSFGenus plc
$31.07+0.00%
BOEUFBonesupport Holding AB (publ)
$24.43+0.00%
GTBIFGreen Thumb Industries Inc.
$7.25-3.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About EKTAF

What is the current price of Elekta Ab (publ)?

Elekta Ab (publ) is trading at $5.21 per share.

What is the 52-week range for Elekta Ab (publ)?

Over the past 52 weeks, Elekta Ab (publ) has traded between $4.48 and $6.83.

How much debt does Elekta Ab (publ) have?

As of the most recent reporting period, Elekta Ab (publ) reported total debt of SEK 715.93M.

How much cash does Elekta Ab (publ) have on hand?

Elekta Ab (publ) reported SEK 241.61M in cash and cash equivalents in its most recent financial results.

What is Elekta Ab (publ)’s dividend yield?

Elekta Ab (publ) currently has a dividend yield of 4.91%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services